(1)
Hyperthermic Vs Normothermic Mitomycin C for Intermediate-Risk NMIBC: A Real-World Retrospective Cohort Study. Arch Ital Urol Androl 2025, 97 (4). https://doi.org/10.4081/aiua.2025.14167.